查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1304503

全球营养保健品配料市场 - 2023-2030

Global Nutraceutical Ingredients Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概述

2022年，全球营养保健品配料市场规模达到1745亿美元，预计到2030年将达到3275亿美元，实现利润丰厚的增长。在预测期内（2023-2030年），全球营养保健品配料市场预计将呈现8.4%的复合年增长率。

营养保健品具有多种益处，包括改善健康状况、延缓衰老、预防慢性疾病、延长预期寿命以及支持身体结构和功能。它们还可用于预防和治疗精神健康问题和疾病。保健食品成分可作为膳食补充剂广泛获取，因此很容易纳入人们的日常生活。它们为那些可能无法仅从饮食中获得足够营养的人们提供了一种简单的解决方案。

市场动态

慢性病发病率上升

糖尿病、高血压、癌症等慢性病发病率的上升将推动市场的增长。慢性疾病，尤其是肥胖症和糖尿病，是老年人的主要担忧。例如，全球糖尿病患病率的上升推动了市场的扩张。根据国际糖尿病联合会的数据，到2021年，约有5370亿人患有糖尿病，占全球每10人中的1人。

预计到2030年将达到6430亿，到2045年将达到7830亿。此外，每四个糖尿病患者中就有三个生活在中低收入国家。2021年，每5秒钟就有1人死于糖尿病，全球死亡人数将近67亿。预计2021年糖尿病医疗支出将超过9660亿美元，比前15年增长316%。因此，疾病的增加将有助于推动市场增长。

强化食品的增加

强化食品的增加是预测期内市场增长的主要驱动力之一。例如，根据澳大利亚政府组织CSIRO（联邦科学与工业研究组织）的预测，到2030年，强化食品和功能性食品的需求将达到97亿美元，年增长率约为3%。随着世界人口的持续增长和消费者偏好的转变，市场对强化食品和功能性食品的需求预计将保持强劲。

该行业的特点是产品结构多样化，从老年消化系统和心血管健康膳食到新生儿和幼儿成长食品，应有尽有。预计到2030年，强化食品和功能性食品的国内市场规模将达到55亿美元，出口机会为42亿美元。

营养保健品原料成本高昂

营养保健品配料应用广泛，包括动物营养品、药品、功能性食品和饮料以及个人护理用品。另一方面，在药品、饲料产品、食品和饮料以及个人护理用品中添加营养保健品成分会提高最终产品的价格。最终产品的价格上涨阻碍了行业的发展，因为大多数消费者都避免购买昂贵的食品，而选择天然食品。

COVID-19影响分析

COVID-19大流行对全球保健品配料业务产生了负面影响。疫情扰乱了原材料供应链，导致短缺和价格变动。生产设施的关闭和运输限制也导致市场增长大幅下降。疫情引发的经济衰退降低了消费者的消费能力，导致对高价营养保健品成分的需求下降。

俄乌战争影响分析

据估计，俄乌冲突对全球保健品原料市场的影响不大，因为该地区的主要市场参与者较少。然而，在预测期内，营养保健品进出口对全球营养保健品成分市场增长的影响预计不大。

目录

第一章 研究方法和范围

  • 研究方法
  • 研究目的和报告范围

第2章：定义和概述

第三章：执行摘要

  • 按产品类型分類的市场摘要
  • 按形态分類的市场摘要
  • 按健康益处分類的市场片段
  • 按应用市场划分
  • 按地区分類的市场摘要

第四章：市场动态

  • 影响因素
    • 驱动因素慢性疾病发病率增加
    • 强化食品的增加
  • 限制因素
    • 营养保健品原料成本高
  • 机会
    • 营养保健品配料行业的创新
  • 影响分析

第五章 行业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 法规分析

第六章：COVID-19分析

  • COVID-19分析
    • COVID-19之前的情况
    • COVID-19期间的情景
    • COVID-19之后的情景
  • COVID-19期间的定价动态
  • 供求关系
  • 大流行期间与市场相关的政府倡议
  • 制造商的战略倡议
  • 结论

第七章：按产品类型

  • 益生菌
  • 蛋白质和氨基酸
  • 植物化学物和植物提取物
  • 纤维和特殊碳水化合物
  • 欧米伽-3脂肪酸
  • 维生素
  • 益生元
  • 类胡萝卜素
  • 矿物质
  • 其他

第八章：按形态分类

  • 干
  • 液体

第九章：按健康益处分类

  • 认知健康
  • 肠道健康
  • 心脏健康
  • 骨骼健康
  • 免疫
  • 营养
  • 体重管理
  • 其他

第10章：按应用分类

  • 食品
    • 零食
    • 糖果
    • 烘焙食品
    • 乳制品
    • 肉类及肉制品
    • 婴儿食品
    • 其他食品
  • 饮料
    • 能量饮料
    • 果汁饮料
    • 健康饮料
    • 个人护理
    • 动物营养
    • 膳食补充剂

第十一章：按地区划分

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 法国
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美其他地区
  • 亚太地区
    • 中国
    • 日本
    • 日本
      • 亚太其它地区
  • 中东和非洲
    • 主要地区动态

第十二章 ：竞争格局

  • 竞争格局
  • 市场定位/份额分析
  • 合併与收购分析

第十三章 ：公司简介

  • Associated British Foods
    • 公司概况
    • 产品组合和描述
    • 财务概况
    • 主要发展
  • Arla Foods
  • DSM
  • Ingredients
  • Tate & Lyle
  • Ajinomoto
  • CHR. Hansen
  • Kyowa Hakko Kirin Group
  • Glanbia Plc
  • Fonterra Co-Operative Group Limited

第十四章：附录

简介目录
Product Code: FB418

Market Overview

The Global Nutraceutical Ingredients Market reached US$ 174.5 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 327.5 billion by 2030. the global nutraceutical ingredients market is expected to exhibit a CAGR of 8.4% during the forecast period (2023-2030).

Nutraceuticals provide multiple benefits, including improved health, slowed ageing, prevention of chronic illnesses, increased life expectancy, and support of the body's structure and functioning. They are also used to prevent and treat mental health concerns and illnesses. Nutraceutical ingredients are widely accessible as dietary supplements, making them easy to include into one's everyday routine. They offer a simple solution for folks who may not get enough nutrients from their diet alone.

Market Dynamics

Increase in Incidence of Chronic Diseases

The rising prevalence of chronic diseases such as diabetes, high blood pressure, cancer, and others would propel the market's growth rate. Chronic diseases, particularly obesity and diabetes, are a major source of concern among the elderly. For instance, the rising prevalence of diabetes around the world is driving market expansion. According to the International Diabetes Federation, approximately 537 Billion individuals will have diabetes by 2021, accounting for one out of every ten people worldwide.

It is expected to reach 643 Billion by 2030, and 783 Billion by 2045. Furthermore, three out of every four persons with diabetes live in low- and middle-income nations. Diabetes claimed one life every five seconds in 2021, accounting for nearly 6.7 Billion fatalities worldwide. Diabetes healthcare spending in 2021 is expected to be over $ 966 billion, representing a 316% increase over the previous 15 years. Thus rise of diseases will helps drive the market growth.

Rise in Fortified Foods

Rise in fortified foods is one of the key driver that helps the market to grow during forecast period. For instance, according to the CSIRO (Commonwealth Scientific and Industrial Research Organisation), an Australian government organisation, demand for fortified and functional foods is predicted to reach $9.7 billion by 2030, with an annual growth rate of roughly 3%. With the world's population continuing to grow and consumer preferences shifting, market demand for fortified and functional foods is expected to stay robust.

The industry is distinguished by a diverse product mix that includes everything from meals for old digestive and cardiovascular health to foods for newborn and toddler growth. The domestic market for fortified and functional goods is estimated to reach $5.5 billion by 2030, with an opportunity for exports of $4.2 billion.

High Cost of Nutraceutical Ingredients

Nutraceutical ingredients are employed in a variety of applications, including animal nutrition, medicines, functional food and drinks, and personal care items. The incorporation of nutraceutical ingredients in medicines, feed products, food and beverage goods, and personal care items, on the other hand, raises the final product price. The increasing expense of the end products stifles industry expansion since most customers avoid purchasing expensive food items in favour of natural ones.

COVID-19 Impact Analysis

The pandemic of COVID-19 has a negative impact on the worldwide nutraceutical ingredients business. The epidemic disrupted the raw material supply chain, resulting in shortages and price changes. Closures of production facilities and transportation limitations also contributed to a major reduction in market growth. The pandemic-caused economic downturn lowered consumer spending power, resulting in lower demand for high-priced nutraceutical components.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is estimated to have a moderate impact on the global nutraceutical ingredients market, owing to the low number of key market players in this region. However, the impact of the import and export of nutraceutical is expected to have little influence over the global nutraceutical ingredients market growth over the forecast period.

Segment Analysis

The global nutraceutical ingredients market is segmented based on product type , form, health benefits, application and region.

Proteins Product Type Segment Accounts for 32.9 % of Market Share.

Probiotics product type segment with around 32.9% is expected to dominate during the forecast period. Proteins are critical macronutrients that aid in tissue growth and repair, muscle mass maintenance, and immune system support. As a result, they are in great demand for the manufacture of nutritional supplements and functional foods.

Since, the rising incidence of lifestyle disorders such as obesity, diabetes, and cardiovascular disease has increased demand for protein-based nutraceutical products, which are recognised to aid in weight reduction, blood sugar regulation, and cardiovascular health. Plant-based protein sources such as soy, pea, and rice protein are in high demand due to the rising popularity of plant-based and vegan diets.

Furthermore, technical improvements in protein extraction and isolation techniques have made it possible to create high-quality protein components at a cheaper cost, driving the protein section of the nutraceutical ingredients market forward.

Geographical Analysis

North America Accounted for Approximately 38.4% of the Market Share 2022

North America is estimated to hold about 38.4 % of the total market share throughout the forecast period. North America is predicted to have good market growth since customers are willing to pay a premium for healthier items due to their increased income and buying power. With increased health and fitness concerns, there is a growing consumption of nutraceutical ingredients loaded nutritious meals. In online retail establishments, nutraceutical ingredients enriched with nutritious meals are widely available. The rapid expansion of functional beverages will drive market growth.

Competitive Landscape

The major global players in the nutraceutical ingredients market include: Associated British Foods, Arla Foods, DSM, Ingredients, Tate & Lyle, Ajinomoto, CHR. Hansen, Kyowa Hakko Kirin Group, Glanbia Plc, and Fonterra Co-Operative Group Limited.

Why Purchase the Report?

  • To visualize the global nutraceutical ingredients market segmentation based on product type, form, health benefits, application and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of nutraceutical ingredients market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global nutraceutical ingredients market report would provide approximately 53 tables, 54 figures and 195 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet By Product Type
  • 3.2. Market Snippet By Form
  • 3.3. Market Snippet By Health Benefits
  • 3.4. Market Snippet By Application
  • 3.5. Market Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. DriversIncrease in Incidences of Chronic Diseases
    • 4.1.2. Rise in Fortified Foods
  • 4.2. Restraints
    • 4.2.1. High Cost of Nutraceutical Ingredients
  • 4.3. Opportunity
    • 4.3.1. Innovations in Nutraceutical Ingredients Industry
  • 4.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post Covid-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Probiotics *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Proteins and Amino Acids
  • 7.4. Phytochemical & Plant Extracts
  • 7.5. Fibers & Specialty Carbohydrates
  • 7.6. Omega-3 Fatty Acids
  • 7.7. Vitamins
  • 7.8. Prebiotic
  • 7.9. Carotenoids
  • 7.10. Minerals
  • 7.11. Others

8. By Form

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 8.1.2. Market Attractiveness Index, By Form
  • 8.2. Dry *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Liquid

9. By Health Benefits

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Health Benefits
    • 9.1.2. Market Attractiveness Index, By Health Benefits
  • 9.2. Cognitive Health *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Gut Health
  • 9.4. Heart Health
  • 9.5. Bone Health
  • 9.6. Immunity
  • 9.7. Nutrition
  • 9.8. Weight Management
  • 9.9. Others

10. By Application

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.1.2. Market Attractiveness Index, By Application
  • 10.2. Food *
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 10.2.3. Snacks
    • 10.2.4. Confectionery
    • 10.2.5. Bakery
    • 10.2.6. Dairy
    • 10.2.7. Meat & Meat Products
    • 10.2.8. Baby Food
    • 10.2.9. Others
  • 10.3. Beverages
    • 10.3.1. Energy Drinks
    • 10.3.2. Juices
    • 10.3.3. Health Drinks
    • 10.3.4. Personal Care
    • 10.3.5. Animal Nutrition
    • 10.3.6. Dietary Supplement

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Health Benefits
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. The U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Health Benefits
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. The U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Spain
      • 11.3.7.5. Italy
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Health Benefits
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia-Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Health Benefits
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan

Australia

      • 11.5.7.4. Rest of Asia-Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Health Benefits
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Market Positioning/Share Analysis
  • 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Associated British Foods *
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Financial Overview
    • 13.1.4. Key Developments
  • 13.2. Arla Foods
  • 13.3. DSM
  • 13.4. Ingredients
  • 13.5. Tate & Lyle
  • 13.6. Ajinomoto
  • 13.7. CHR. Hansen
  • 13.8. Kyowa Hakko Kirin Group
  • 13.9. Glanbia Plc
  • 13.10. Fonterra Co-Operative Group Limited

LIST NOT EXHAUSTIVE

14. Appendix

  • 14.1. About Us and Services
  • 14.2. Contact Us